Navigation Links
Behavioral therapy in pediatric antidepressant treatment reduces likelihood of relapse
Date:7/2/2014

DALLAS July 2, 2014 Cognitive behavioral therapy in addition to medication improves the long-term success of treatment for children and adolescents suffering from depression, a new UTSouthwestern Medical Center study indicates.

Based on the results of a clinical trial conducted at UTSouthwestern and Children's Medical Center of Dallas, depression relapse rates were substantially lower in a group of youth who received both forms of treatment versus medication alone.

"Continuation-phase strategies designed to reduce the high rates of relapse in depressed youths have important public health implications, as recurrence of depression is more likely in youths with multiple episodes," said Dr. Betsy Kennard, Professor of Psychiatry at UTSouthwestern and senior author of the study published June 17 in The American Journal of Psychiatry.

Relapse rates in youth with major depressive disorders typically range from 40 percent to 70 percent, said Dr. Kennard, also Director of an outpatient program at Children's Medical Center called Suicide Prevention and Resilience at Children's (SPARC).

In this study, the relapse rate for the group of 75 youth who received behavioral therapy for six months following six weeks of initial treatment with the antidepressant fluoxetine, also known as Prozac, was 9 percent. Among the group of 69 youth who received only the drug during this period, 26.5 percent relapsed.

Youth who showed improvement after receiving fluoxetine for an initial six-week treatment period continued in the study, split between the medication-only and therapy plus medication groups. Study participants' ages ranged from 8-17.

"Unfortunately, medication alone is not always enough to prevent relapse," said Dr. Graham Emslie, Chief of the Division of Adolescent and Child Psychiatry, Professor of Psychiatry and Pediatrics at UTSouthwestern, and a contributing author of the study. "Identifying novel strategies to prevent future relapses for young people should be a priority. This approach is unique in that treatment was added at a time when the intensity of care is frequently decreasing."

The type of therapy used in this trial called Relapse Prevention Cognitive Behavioral Therapy is an individual psychotherapy treatment with a family component that focuses on reducing residual symptoms, increasing wellness behaviors, and preventing relapse. For six months, the youth in this arm of the trial participated in eight to 11 therapy sessions that were tailored to each child.

"It is also worth noting that youth who received the therapy had lower medication doses, yet had better outcomes than those on higher dosages in the medication management-only group," said Dr. Kennard.


'/>"/>

Contact: Debbie Bolles
debbie.bolles@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Lead in kids blood linked with behavioral and emotional problems
2. NYU researchers pilot educational and behavioral program to reduce lymphedema risk
3. Cognitive behavioral or relaxation training helps women reduce distress during breast cancer treatment
4. IADR and Unilever partner to launch new behavioral research award
5. New project on psychiatric, neurologic, and behavioral genetics
6. Adding cognitive behavioral therapy to treatment of pediatric migraine improves relief of symptoms
7. Susquehanna Health Behavioral Health Professional Addresses Mental Health Parity
8. Mississippi Department of Mental Health Selects CoCENTRIX for EHR and to Coordinate Care for Its Citizens Treated in State Behavioral Health and I/DD Programs
9. Experts Examine the Success of Cognitive Behavioral Therapy in Treating Depression Among Older Veterans
10. The 54th National Dialogues on Behavioral Health Conference Prepares Behavioral Health Organizations for Evolving Markets on Eve of ACA Implementation
11. Study suggests antioxidant treatment may help NF1-linked behavioral issues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Behavioral therapy in pediatric antidepressant treatment reduces likelihood of relapse
(Date:12/2/2016)... ... 2016 , ... Advanced Inc., a leading provider of travel therapy and travel ... serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served ... and operational leadership experience to Advanced Inc. He began his career in finance at ...
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. Vivek ... Dr. Murthy explains how he was inspired to practice medicine at an early age ... is about more than making diagnoses and prescribing medicine,” he states. “It is about ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than half of American teens report losing ... report speaking with their child about sex related topics, less than 60 percent spoke ... proud to announce the launch of its second edition of the “Sexual Wellness” campaign, ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic imaging ... Heart at their tradeshow booth # 941 for the American Association of Equine ...
(Date:12/2/2016)... ... ... "Pro3rd Accents Volume 2 is a set of 30 accented lower third ... a few clicks of the mouse," said Christina Austin - CEO of Pixel Film ... various styles with accented animations, rigid boxes, simplistic lines, and more. In Addition, users ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Research and Markets has announced the addition of Jain ... and Companies" to their offering. ... , , Drug ... market value of drug delivery technologies and the anticancer drugs are ... to organs involved and the types of cancer as well as ...
(Date:12/2/2016)... , Dec. 1, 2016 Around the corners ... region and each habitable land present over earth. Cancer ... individual once in a life time this is because ... available until now. Given the steady increase in global ... with the spiraling healthcare costs of treatment, there is ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a leading global ... Accelerated Share Repurchase (ASR) Program. Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO ... , ... the Company entered into a variable tenor ASR arrangement on  ... billion of its ordinary shares. Approximately 40.5 million shares worth ...
Breaking Medicine Technology: